Home > Compound List > Product Information
7,8-Dihydroxyflavone hydrate_Molecular_structure_CAS_38183-03-8(anhydrous))
Click picture or here to close

7,8-Dihydroxyflavone hydrate

Catalog No. D5446 Name Sigma Aldrich
CAS Number 38183-03-8(anhydrous) Website http://www.sigmaaldrich.com
M. F. C15H10O4 Telephone 1-800-521-8956
M. W. 254.2375 Fax
Purity ≥98% (HPLC) Email
Storage desiccated Chembase ID: 154718

SYNONYMS

IUPAC name
7,8-dihydroxy-2-phenyl-4H-chromen-4-one
IUPAC Traditional name
7,8-dihydroxy-2-phenylchromen-4-one

DATABASE IDS

MDL Number MFCD00006836
EC Number 253-812-4
CAS Number 38183-03-8(anhydrous)

PROPERTIES

Empirical Formula (Hill Notation) C15H10O4 · xH2O
Purity ≥98% (HPLC)
Apperance solid
Solubility DMSO: soluble24 mg/mL
GHS Pictograms GHS07
GHS Signal Word Warning
GHS Hazard statements H302
European Hazard Symbols Harmful Harmful (Xn)
MSDS Link Download
Risk Statements 22
RTECS DJ3004000
Storage Condition desiccated
Storage Temperature room temp
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
7,8-Dihydroxyflavone is a selective tyrosine kinase receptor B (TrkB) receptor agonist. It manifests all the therapeutic effects of brain-derived neurotrophic factor (BDNF)-such as protecting neurons from apoptosis, inhibiting kainic acid-induced toxicity, decreasing infarct volumes in stroke, and neuroprotecting in an animal model of Parkinson′s disease-without the poor pharmacokinetic profile of BDNF limiting its therapeutic potential.1
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. D5446.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.
Description (简体中文)
Biochem/physiol Actions
7,8-Dihydroxyflavone is a selective tyrosine kinase receptor B (TrkB) receptor agonist. It manifests all the therapeutic effects of brain-derived neurotrophic factor (BDNF)-such as protecting neurons from apoptosis, inhibiting kainic acid-induced toxicity, decreasing infarct volumes in stroke, and neuroprotecting in an animal model of Parkinson′s disease-without the poor pharmacokinetic profile of BDNF limiting its therapeutic potential.1
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. D5446.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.

REFERENCES